Emcure Pharmaceuticals Shareholding Pattern
- Market cap
- ₹36,312 crore
- P/E
- 35.9
- P/B
- 7.34
- ROE
- 19.7%
- Dividend yield
- 0.19%
As of 30-JUN-2026, promoters held 77.83% of Emcure Pharmaceuticals (-0.04 pp from 31-MAR-2026), foreign institutional investors 4.88%, domestic institutions 8.46% and the public 8.83%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Emcure Pharmaceuticals shareholding pattern — frequently asked questions
What is the promoter holding in Emcure Pharmaceuticals?
Promoters held 77.83% of Emcure Pharmaceuticals as of 30-JUN-2026, down 0.04 pp from 77.87% in 31-MAR-2026.
How much do FIIs hold in Emcure Pharmaceuticals?
Foreign institutional investors held 4.88% of Emcure Pharmaceuticals as of 30-JUN-2026, a change of +1.53 pp from the previous quarter.
How much do domestic institutions hold in Emcure Pharmaceuticals?
Domestic institutional investors, including mutual funds and insurers, held 8.46% of Emcure Pharmaceuticals as of 30-JUN-2026 (+2.36 pp from the previous quarter).
Who owns Emcure Pharmaceuticals?
As of 30-JUN-2026, Emcure Pharmaceuticals' shareholders were promoters (77.83%), foreign institutional investors 4.88%, domestic institutions 8.46% and the public 8.83%, as filed with the stock exchanges.
Same Data For Peers
Trade Emcure Pharmaceuticals With ATS
Track EMCURE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.